We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EAF:NYSEGrafTech International Ltd. Analysis

Data as of 2026-03-30 - not real-time

$6.18

Latest Price

8/10Risk

Risk Level: High

Executive Summary

GrafTech’s shares are trading at $6.18, well beneath the 20‑day, 50‑day and 200‑day moving averages of roughly $6.0, $9.3 and $12.4, underscoring a pronounced bearish price trend. The 14‑day RSI sits in the low‑40s, indicating modest oversold pressure but not a clear reversal signal. Although the MACD histogram is positive, the line remains negative, offering only a tentative bullish hint. The stock is perched near its technical support of $4.92, with a nearby resistance around $8.0, limiting upside in the near term. Volatility is extreme at over 70%‑annualized and beta exceeds 2, meaning price swings are amplified relative to the market. Historical drawdowns have approached 74%, reflecting a history of steep declines. On the fundamentals side, revenue fell 13% year‑over‑year and margins are deeply negative, with operating margin below –30% and a net loss per share of $8.45. Cash on hand (~$138 M) is dwarfed by debt exceeding $1 B, and operating cash flow is strongly negative, raising solvency concerns. Recent headlines flag multiple shareholder‑rights lawsuits and a pending trade investigation into Chinese and Indian graphite imports, adding legal and regulatory headwinds.
The market values the company at a price‑to‑sales multiple of just 0.32, far below the industry average, and analysts project a mean target of $8.75, implying roughly 42% upside versus current levels. However, the Fear & Greed Index is in “Greed” territory, suggesting that the modest upside may be overstated by market optimism. The stock pays no dividend and its book value per share is negative, confirming that dividend sustainability is nonexistent. Given the confluence of weak earnings, high leverage, elevated volatility, and ongoing litigation, the overall risk profile is high, and the investment case remains speculative. Consequently, the recommendation leans toward a cautious stance, with short‑ to medium‑term holds and a longer‑term bias toward exiting the position unless a clear turnaround materializes.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with bearish moving averages
  • Decreasing volume and high volatility
  • Ongoing shareholder‑rights litigation

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative earnings trends and high debt load
  • Potential impact of trade investigation on graphite supply
  • Continued cash‑flow deficits

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Structural weakness in steel and graphite markets
  • Elevated beta and historical drawdowns
  • Lack of dividend and negative book value

Key Metrics & Analysis

Financial Health

Revenue Growth-13.20%
Profit Margin-43.61%
P/E Ratio-9.6
ROA-4.09%
P/B Ratio-0.6
Op. Cash Flow$-81616000
Free Cash Flow$-60302248
Industry P/E27.9

Technical Analysis

TrendBearish
RSI41.3
Support$4.92
Resistance$8.00
MA 20$6.00
MA 50$9.29
MA 200$12.44
MACDBullish
VolumeDecreasing
Fear & Greed Index67.64

Valuation

Target Price$8.75
Upside/Downside41.70%
GradeUndervalued
TypeValue

Risk Assessment

Beta2.16
Volatility73.50%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.